Iatrogenic Cushing Syndrome and Secondary Adrenal Insufficiency in a Child due to Topical Ocular Corticosteroids: A Case Report

Introduction: Iatrogenic Cushing syndrome (ICS) can be caused by synthetic glucocorticoids administered through various routes. ICS caused by corticosteroid eye drops is an exceptional event, being more frequent in pediatric age. Herein, we describe a case of ICS associated with secondary...

Full description

Saved in:
Bibliographic Details
Main Authors: Joana Santos-Oliveira, Luís Torrão, Sónia Torres-Costa, Marta Silva, Ana Catarina Pedrosa, Joana Araújo, Luís Figueira, Cláudia Oliveira-Ferreira
Format: Article
Language:English
Published: Karger Publishers 2025-02-01
Series:Case Reports in Ophthalmology
Online Access:https://karger.com/article/doi/10.1159/000543908
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849321627728216064
author Joana Santos-Oliveira
Luís Torrão
Sónia Torres-Costa
Marta Silva
Ana Catarina Pedrosa
Joana Araújo
Luís Figueira
Cláudia Oliveira-Ferreira
author_facet Joana Santos-Oliveira
Luís Torrão
Sónia Torres-Costa
Marta Silva
Ana Catarina Pedrosa
Joana Araújo
Luís Figueira
Cláudia Oliveira-Ferreira
author_sort Joana Santos-Oliveira
collection DOAJ
description Introduction: Iatrogenic Cushing syndrome (ICS) can be caused by synthetic glucocorticoids administered through various routes. ICS caused by corticosteroid eye drops is an exceptional event, being more frequent in pediatric age. Herein, we describe a case of ICS associated with secondary adrenal insufficiency (SAI) caused by ocular topical corticosteroid treatment. Case Presentation: An 11-year-old girl was referred to our ocular inflammation department due to idiopathic, chronic, non-hypertensive, non-granulomatous bilateral anterior uveitis, treated with topical dexamethasone (eye drops, 1 mg/mL) for 1 year. During the past year, the child and her mother observed a gradual change in her physical appearance, particularly noting the development of a cushingoid facial appearance. Laboratory data revealed morning serum adrenocorticotropic hormone (ACTH) of 3.6 ng/L (7.2–63.3) and morning serum cortisol of 0.20 µg/dL (6.2–19.4). She was treated with methotrexate (15 mg/week, orally), and the topical corticosteroid regimen was progressively tapered and discontinued after 3 months. Nine months after the patient discontinued corticosteroid eye drops, her cushingoid face disappeared, and her laboratory data improved. Regarding the ophthalmological examination, the uveitis remained in remission with methotrexate, with no new episodes of intraocular inflammation. Conclusion: Although rare, ophthalmologists must be aware of ICS and SAI and prioritize using the least potent corticosteroid for the shortest duration necessary. Additionally, clinicians should avoid abrupt cessation of long-term corticosteroid therapy as this can precipitate an adrenal crisis in the presence of adrenal insufficiency.
format Article
id doaj-art-b1183c8cfe6d40618ada0ea154c45bcc
institution Kabale University
issn 1663-2699
language English
publishDate 2025-02-01
publisher Karger Publishers
record_format Article
series Case Reports in Ophthalmology
spelling doaj-art-b1183c8cfe6d40618ada0ea154c45bcc2025-08-20T03:49:41ZengKarger PublishersCase Reports in Ophthalmology1663-26992025-02-0116119420110.1159/000543908Iatrogenic Cushing Syndrome and Secondary Adrenal Insufficiency in a Child due to Topical Ocular Corticosteroids: A Case ReportJoana Santos-Oliveirahttps://orcid.org/0000-0003-0260-8469Luís Torrãohttps://orcid.org/0000-0003-0555-6860Sónia Torres-Costahttps://orcid.org/0000-0002-7079-9554Marta Silvahttps://orcid.org/0009-0000-5906-6061Ana Catarina Pedrosahttps://orcid.org/0000-0001-6831-5488Joana Araújohttps://orcid.org/0000-0002-6140-096XLuís Figueirahttps://orcid.org/0000-0002-4481-882XCláudia Oliveira-Ferreirahttps://orcid.org/0000-0002-9446-7140 Introduction: Iatrogenic Cushing syndrome (ICS) can be caused by synthetic glucocorticoids administered through various routes. ICS caused by corticosteroid eye drops is an exceptional event, being more frequent in pediatric age. Herein, we describe a case of ICS associated with secondary adrenal insufficiency (SAI) caused by ocular topical corticosteroid treatment. Case Presentation: An 11-year-old girl was referred to our ocular inflammation department due to idiopathic, chronic, non-hypertensive, non-granulomatous bilateral anterior uveitis, treated with topical dexamethasone (eye drops, 1 mg/mL) for 1 year. During the past year, the child and her mother observed a gradual change in her physical appearance, particularly noting the development of a cushingoid facial appearance. Laboratory data revealed morning serum adrenocorticotropic hormone (ACTH) of 3.6 ng/L (7.2–63.3) and morning serum cortisol of 0.20 µg/dL (6.2–19.4). She was treated with methotrexate (15 mg/week, orally), and the topical corticosteroid regimen was progressively tapered and discontinued after 3 months. Nine months after the patient discontinued corticosteroid eye drops, her cushingoid face disappeared, and her laboratory data improved. Regarding the ophthalmological examination, the uveitis remained in remission with methotrexate, with no new episodes of intraocular inflammation. Conclusion: Although rare, ophthalmologists must be aware of ICS and SAI and prioritize using the least potent corticosteroid for the shortest duration necessary. Additionally, clinicians should avoid abrupt cessation of long-term corticosteroid therapy as this can precipitate an adrenal crisis in the presence of adrenal insufficiency.https://karger.com/article/doi/10.1159/000543908
spellingShingle Joana Santos-Oliveira
Luís Torrão
Sónia Torres-Costa
Marta Silva
Ana Catarina Pedrosa
Joana Araújo
Luís Figueira
Cláudia Oliveira-Ferreira
Iatrogenic Cushing Syndrome and Secondary Adrenal Insufficiency in a Child due to Topical Ocular Corticosteroids: A Case Report
Case Reports in Ophthalmology
title Iatrogenic Cushing Syndrome and Secondary Adrenal Insufficiency in a Child due to Topical Ocular Corticosteroids: A Case Report
title_full Iatrogenic Cushing Syndrome and Secondary Adrenal Insufficiency in a Child due to Topical Ocular Corticosteroids: A Case Report
title_fullStr Iatrogenic Cushing Syndrome and Secondary Adrenal Insufficiency in a Child due to Topical Ocular Corticosteroids: A Case Report
title_full_unstemmed Iatrogenic Cushing Syndrome and Secondary Adrenal Insufficiency in a Child due to Topical Ocular Corticosteroids: A Case Report
title_short Iatrogenic Cushing Syndrome and Secondary Adrenal Insufficiency in a Child due to Topical Ocular Corticosteroids: A Case Report
title_sort iatrogenic cushing syndrome and secondary adrenal insufficiency in a child due to topical ocular corticosteroids a case report
url https://karger.com/article/doi/10.1159/000543908
work_keys_str_mv AT joanasantosoliveira iatrogeniccushingsyndromeandsecondaryadrenalinsufficiencyinachildduetotopicalocularcorticosteroidsacasereport
AT luistorrao iatrogeniccushingsyndromeandsecondaryadrenalinsufficiencyinachildduetotopicalocularcorticosteroidsacasereport
AT soniatorrescosta iatrogeniccushingsyndromeandsecondaryadrenalinsufficiencyinachildduetotopicalocularcorticosteroidsacasereport
AT martasilva iatrogeniccushingsyndromeandsecondaryadrenalinsufficiencyinachildduetotopicalocularcorticosteroidsacasereport
AT anacatarinapedrosa iatrogeniccushingsyndromeandsecondaryadrenalinsufficiencyinachildduetotopicalocularcorticosteroidsacasereport
AT joanaaraujo iatrogeniccushingsyndromeandsecondaryadrenalinsufficiencyinachildduetotopicalocularcorticosteroidsacasereport
AT luisfigueira iatrogeniccushingsyndromeandsecondaryadrenalinsufficiencyinachildduetotopicalocularcorticosteroidsacasereport
AT claudiaoliveiraferreira iatrogeniccushingsyndromeandsecondaryadrenalinsufficiencyinachildduetotopicalocularcorticosteroidsacasereport